Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -8.42% is 222% below its 5-year average of 6.89%, near the low end of its 5-year range (-14.77%–54.91%).
As of the fiscal period ended Tuesday, June 30, 2026. 43.84% below its 12-month average of -5.86%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -8.42%.
RETURN ON EQUITY (ROE)
-8.42%
RETURN ON EQUITY (ROE) AVG TTM
-5.86%
RETURN ON EQUITY (ROE) AVG 3Y
-8.00%
RETURN ON EQUITY (ROE) AVG 5Y
6.89%
RETURN ON EQUITY (ROE) AVG 10Y
-5.69%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-43.84%
CURRENT VS 3Y AVG
-5.35%
CURRENT VS 5Y AVG
-222.28%
CURRENT VS 10Y AVG
-47.94%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-36.00%
median of 392 covered companies
CURRENT VS SECTOR MEDIAN
+76.60%
vs the sector median at left
Fulgent Genetics, Inc.
Market Cap
$637.59M
Return on Equity (ROE)
-8.42%
TTM Avg
-5.86%
3Y Avg
-8.00%
5Y Avg
6.89%
Market Cap
$642.31M
Return on Equity (ROE)
-21.51%
TTM Avg
-20.05%
3Y Avg
-35.91%
5Y Avg
-26.18%
Market Cap
$632.76M
Return on Equity (ROE)
-24.06%
TTM Avg
-36.09%
3Y Avg
-34.99%
5Y Avg
-44.03%
Market Cap
$643.37M
Return on Equity (ROE)
-41.56%
TTM Avg
-67.38%
3Y Avg
-49.66%
5Y Avg
-56.07%
Market Cap
$675.41M
Return on Equity (ROE)
-43.95%
TTM Avg
-29.61%
3Y Avg
-34.61%
5Y Avg
-30.48%
Market Cap
$596.36M
Return on Equity (ROE)
-60.79%
TTM Avg
-73.94%
3Y Avg
-62.04%
5Y Avg
-71.62%
Market Cap
$688.14M
Return on Equity (ROE)
-108.93%
TTM Avg
-72.41%
3Y Avg
-64.95%
5Y Avg
-55.74%
Market Cap
$579.88M
Return on Equity (ROE)
N/A
TTM Avg
44.05%
3Y Avg
44.05%
5Y Avg
44.05%
Market Cap
$698.60M
Return on Equity (ROE)
-113.05%
TTM Avg
-95.98%
3Y Avg
-72.88%
5Y Avg
-73.85%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fulgent Genetics, Inc. (FLGT) | $637.59M | -8.42% | -5.86% | -8.00% | 6.89% |
| AngioDynamics, Inc. (ANGO)vs › | $642.31M | -21.51% | -20.05% | -35.91% | -26.18% |
| Climb Bio, Inc. (CLYM)vs › | $632.76M | -24.06% | -36.09% | -34.99% | -44.03% |
| Aura Biosciences, Inc. (AURA)vs › | $643.37M | -41.56% | -67.38% | -49.66% | -56.07% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $675.41M | -43.95% | -29.61% | -34.61% | -30.48% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $596.36M | -60.79% | -73.94% | -62.04% | -71.62% |
| Annexon, Inc. (ANNX)vs › | $688.14M | -108.93% | -72.41% | -64.95% | -55.74% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $579.88M | N/A | 44.05% | 44.05% | 44.05% |
| Faeth Therapeutics, Inc. (FTH)vs › | $698.60M | -113.05% | -95.98% | -72.88% | -73.85% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $573.38M | N/A | 161.13% | 93.89% | 96.07% |
ROE
-8.4%
ROA
-7.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -8.42% |
| 2026-03-31 | -7.03% |
| 2025-12-31 | -5.44% |
| 2025-09-30 | -3.82% |
| 2025-06-30 | -4.57% |
| 2025-03-31 | -3.62% |
| 2024-12-31 | -3.77% |
| 2024-09-30 | -14.49% |
| 2024-06-30 | -14.43% |
| 2024-03-31 | -14.69% |
| 2023-12-31 | -14.77% |
| 2023-09-30 | -5.05% |
| 2023-06-30 | -3.86% |
| 2023-03-31 | -2.05% |
| 2022-12-31 | 11.32% |
| 2022-09-30 | 21.27% |
| 2022-06-30 | 30.07% |
| 2022-03-31 | 35.27% |
| 2021-12-31 | 43.79% |
| 2021-09-30 | 54.91% |
| 2021-06-30 | 54.06% |
| 2021-03-31 | 52.02% |
| 2020-12-31 | 37.64% |
| 2020-09-30 | 25.52% |
| 2020-06-30 | 2.91% |
| 2020-03-31 | -0.56% |
| 2019-12-31 | -0.50% |
| 2019-09-30 | -1.93% |
| 2019-06-30 | -6.08% |
| 2019-03-31 | -8.98% |
| 2018-12-31 | -8.59% |
| 2018-09-30 | -9.85% |
| 2018-06-30 | -10.80% |
| 2018-03-31 | -8.76% |
| 2017-12-31 | -4.65% |
| 2017-09-30 | -0.13% |
| 2017-06-30 | -0.16% |
| 2017-03-31 | -8.27% |
| 2016-12-31 | -9.81% |
| 2016-09-30 | -85.29% |
| 2016-06-30 | -61.00% |
| 2016-03-31 | -128.18% |
| 2015-12-31 | -136.32% |
